Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/11000/31210
CSF-ApoER2 fragments as a read-out of reelin signaling: Distinct patterns in sporadic and autosomal-dominant Alzheimer disease
Ver/Abrir: CSF-ApoER2 fragments as a read-out of reelin signaling Distinct patterns in sporadic and autosomal-dominant Alzheimer disease.pdf
817,24 kB
Adobe PDF
Compartir:
Este recurso está restringido
Título : CSF-ApoER2 fragments as a read-out of reelin signaling: Distinct patterns in sporadic and autosomal-dominant Alzheimer disease |
Autor : Lopez-Font, Inmaculada Iborra Lázaro, Guillermo Sánchez-Valle, Raquel Molinuevo, José Luis Cuchillo-Ibañez, Inmaculada Sáez-Valero, Javier |
Editor : Elsevier |
Fecha de publicación: 2018-12-12 |
URI : https://hdl.handle.net/11000/31210 |
Resumen :
Reelin is a glycoprotein associated with synaptic plasticity and neurotransmission. The malfunctioning of reelin signaling in the brain is likely to contribute to the pathogenesis of Alzheimer's disease (AD). Reelin binding to Apolipoprotein E receptor 2 (ApoER2) activates downstream signaling and induces the proteolytic cleavage of ApoER2, resulting in the generation of soluble fragments. To evaluate the efficiency of reelin signaling in AD, we have quantified the levels of reelin and soluble ectodomain fragments of ApoER2 (ectoApoER2) in the cerebrospinal fluid (CSF). CSF from sporadic AD patients (sAD; n = 14, age 54-83 years) had lower levels of ecto-ApoER2 (~31% reduction; p = .005) compared to those in the age-matched controls (n = 10, age 61-80), and a higher reelin/ecto-ApoER2 ratio. In contrast, autosomal dominant AD patients, carriers of PSEN1 mutations (ADAD; n = 7, age 31-49 years) had higher ecto-ApoER2 levels (~109% increment; p = .001) and a lower reelin/ecto-ApoER2 ratio than the non-mutation carriers from the same families (n = 7, age 25-47 years). Our data suggest that the levels of ecto-ApoER2 in CSF could be a suitable read-out of an impaired reelin signaling in AD, but also indicate differences between sAD and ADAD.
|
Palabras clave/Materias: Reelin ApoER2 Autosomal-dominant AD CSF Proteolytic fragment Sporadic AD |
Tipo documento : application/pdf |
Derechos de acceso: info:eu-repo/semantics/closedAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
DOI : https://doi.org/10.1016/j.cca.2018.12.012 |
Aparece en las colecciones: Instituto de Neurociencias
|
La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.